High-Dose Adenosine Overcomes the Attenuation of Myocardial Perfusion Reserve Caused by Caffeine

Journal of the American College of Cardiology

Volumn 52, Issue 24, 2008, Pages 2008-2016

  Reyes, Eliana ^a,b   Loong, Chee Y ^a,b   Harbinson, Mark ^b   Donovan, Jackie ^b   Anagnostopoulos, Constantinos ^b   Underwood, S Richard ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

adenosine; caffeine; coronary artery disease; myocardial perfusion scintigraphy

Indexed keywords

ADENOSINE; CAFFEINE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CLINICAL ARTICLE; CORONARY ARTERY DILATATION; DIET SUPPLEMENTATION; HEART MUSCLE PERFUSION; HEART RATE; HEART SCINTISCANNING; HUMAN; HYPEREMIA; PRIORITY JOURNAL; SCORING SYSTEM;

ADENOSINE; AGED; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; COFFEE; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG INTERACTIONS; FEMALE; HUMANS; HYPEREMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION IMAGING; PROSPECTIVE STUDIES; RECEPTORS, PURINERGIC P1; VASODILATION; VASODILATOR AGENTS;

EID: 56849096300     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.08.052     Document Type: Article

References (25)

1. Wilson R.F., Wyche K., Christensen B.V., Zimmer S., and Laxson D.D. Effects of adenosine on human coronary arterial circulation. Circulation 82 (1990) 1595-1606
2. Fredholm B.B., Irenius E., Kull B., and Schulte G. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol 61 (2001) 443-448
3. Kull B., Arslan G., Nilsson C., et al. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors. Biochem Pharmacol 57 (1999) 65-75
4. Fredholm B.B., Ijzerman A.P., Jacobson K.A., Klotz K.N., and Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53 (2001) 527-552
5. Smits P., Corstens F.H., Aengevaeren W.R., Wackers F.J., and Thien T. False-negative dipyridamole-thallium-201 myocardial imaging after caffeine infusion. J Nucl Med 32 (1991) 1538-1541
6. Bottcher M., Czernin J., Sun K.T., Phelps M.E., and Schelbert H.R. Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation. J Nucl Med 36 (1995) 2016-2021
7. Zoghbi G.J., Htay T., Aqel R., Blackmon L., Heo J., and Iskandrian A.E. Effect of caffeine on ischemia detection by adenosine single-photon emission computed tomography perfusion imaging. J Am Coll Cardiol 47 (2006) 2296-2302
8. Aqel R.A., Zoghbi G.J., Trimm J.R., Baldwin S.A., and Iskandrian A.E. Effect of caffeine administered intravenously on intracoronary-administered adenosine-induced coronary hemodynamics in patients with coronary artery disease. Am J Cardiol 93 (2004) 343-346
9. Fredholm B.B. Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol 76 (1995) 93-101
10. McCusker R.R., Goldberger B.A., and Cone E.J. Caffeine content of specialty coffees. J Anal Toxicol 27 (2003) 520-522
11. McCusker R.R., Goldberger B.A., and Cone E.J. Caffeine content of energy drinks, carbonated sodas, and other beverages. J Anal Toxicol 30 (2006) 112-114
12. Smits P., Boekema P., De Abreu R., Thien T., and van't Laar A. Evidence for an antagonism between caffeine and adenosine in the human cardiovascular system. J Cardiovasc Pharmacol 10 (1987) 136-143
13. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
14. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
15. Barone J.J., and Roberts H.R. Caffeine consumption. Food Chem Toxicol 34 (1996) 119-129
16. McCusker R.R., Fuehrlein B., Goldberger B.A., Gold M.S., and Cone E.J. Caffeine content of decaffeinated coffee. J Anal Toxicol 30 (2006) 611-613
17. Cornelis M.C., El-Sohemy A., Kabagambe E.K., and Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 295 (2006) 1135-1141
18. Namdar M., Koepfli P., Grathwohl R., et al. Caffeine decreases exercise-induced myocardial flow reserve. J Am Coll Cardiol 47 (2006) 405-410
19. Corti R., Binggeli C., Sudano I., et al. Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content: role of habitual versus nonhabitual drinking. Circulation 106 (2002) 2935-2940
20. Varani K., Portaluppi F., Gessi S., et al. Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects. Circulation 102 (2000) 285-289
21. Holtzman S.G., Mante S., and minneman K.P. Role of adenosine receptors in caffeine tolerance. J Pharmacol Exp Ther 256 (1991) 62-68
22. Smits P., Schouten J., and Thien T. Cardiovascular effects of two xanthines and the relation to adenosine antagonism. Clin Pharmacol Ther 45 (1989) 593-599
23. Gaemperli O., Schepis T., Koepfli P., et al. Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trial. J Am Coll Cardiol 51 (2008) 328-329
24. Riou L.M., Ruiz M., Rieger J.M., et al. Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A(2A)-receptor-mediated coronary vasodilation. J Am Coll Cardiol 40 (2002) 1687-1694
25. Lane D. Menstrual cycle effects on caffeine elimination in the human female. Eur J Clin Pharmacol 43 (1992) 543-546